NASDAQ
Kiromic BioPharma, Inc. (KRBP) has a fcf yield of -84.49% as of Tuesday, August 4, 2026. This represents a 202.34% decrease compared to its 12-month average of -27.95%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.